Navidea Biopharmaceuticals’ Chief Medical Officer Michael Rosol has stepped down. Additionally, the company has hired G2G Ventures as Executive Consultants to provide executive team support for Navidea’s growth plans. Navidea has hired G2G Ventures, a specialized firm led by Dr. Jason Myers, former CEO of ArcherDx and a graduate of the Stanford University School of Medicine, as Executive Consultants. After serving as Chief Medical Officer for the Navidea since 2018, Michael Rosol has decided to step down to pursue opportunities outside the organization. The role of Chief Medical Officer will be assumed by existing leadership with coordinated support from G2G Ventures. Further, Rosol will provide transition consulting services to the company.
Published first on TheFly
